Brivaracetam is a third-generation antiepileptic racetam derivative and a 4-n-propyl analogue of levetiracetam. It is used in the treatment of partial-onset seizures. Brivaracetam binds SV2A with 20 time’s higher affinity than levetiracetam. SV2A is known to play a role in epileptogenesis through modulation of synaptic GABA release. It is thought that brivaracetam exerts its anti-epileptogenic…
Know More
Cerebroprotein hydrolysate is a unique neurotrophic peptidergic mixture produced by standardized enzymatic breakdown of lipid-free porcine brain proteins. It acts like endogenous neurotrophic factors as it consists of short biological peptides. Neurotrophic activity can be detected within 1 day after a single injection. Cerebroprotein hydrolysate-augmented proliferation, differentiation and migration of adult sub ventricular zone (SVZ)…
Know More
Citialfa – P is a nutritional supplement and source of choline and cytidine with potential neuroprotective and nootropic activity. Citicoline, also known as cytidine-5-diphosphocholine or CDP-choline, is hydrolyzed into cytidine and choline in the intestine.
Know More
Brain cells that form part of our complex neuronal network cannot be replaced and have the highest priority in the body for micronutrients. Nutrition can substantially affect mood, behavior, and brain function. thereby influencing mood, sleeping patterns and etc. Deficiencies or excess of certain vitamins or minerals may impair brain function. Usually, the lack of…
Know More
Escipix (Escitalopram) is a selective serotonin re-uptake inhibitor (SSRI) and the S-enantiomer of racemic citalopram. It is used to restore serotonergic function in the treatment of depression and anxiety. Escitalopram is approximately 150 times more potent than citalopram’s R-enantiomer and is responsible for the vast majority of citalopram’s clinical activity, with some evidence suggesting that…
Know More
Gabapentin is a synthetic analogue of the neurotransmitter gamma-aminobutyric acid with anticonvulsant activity. Gabapentin is a structural analogue of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) that was first approved for use in the United States in 1993.It was originally developed as a novel anti-epileptic for the treatment of certain types of seizures1 today it is also widely used to treat neuropathic pain
Know More
